Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised YES on the transaction. Yield Engineering Systems (YES) has announced a $55 million IP-backed financing from a fund managed by Aon Advantage...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Owlet in the financing round. Owlet, Inc. (NYSE: OWLT) announced it has consummated a sale of its newly issued Series A convertible...
You must be a Standard 1 Year member to access this content.
